Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Increased serotonergic neurotransmission is not responsible for the anticompulsive effect of berberine in a murine model of obsessive-compulsive disorder.

Dixit PV, Parihar G, Jain DK, Jaiswal P.

Behav Pharmacol. 2012 Oct;23(7):716-21. doi: 10.1097/FBP.0b013e328358477c.

PMID:
22890212
2.

Genetic depletion of brain 5HT reveals a common molecular pathway mediating compulsivity and impulsivity.

Angoa-Pérez M, Kane MJ, Briggs DI, Sykes CE, Shah MM, Francescutti DM, Rosenberg DR, Thomas DM, Kuhn DM.

J Neurochem. 2012 Jun;121(6):974-84. doi: 10.1111/j.1471-4159.2012.07739.x. Epub 2012 Apr 13.

3.

Combination of aripiprazole and ethanol attenuates marble-burying behavior in mice.

Gaikwad U, Parle M.

Acta Pol Pharm. 2011 May-Jun;68(3):435-40.

4.

Sim1 is a novel regulator in the differentiation of mouse dorsal raphe serotonergic neurons.

Osterberg N, Wiehle M, Oehlke O, Heidrich S, Xu C, Fan CM, Krieglstein K, Roussa E.

PLoS One. 2011 Apr 26;6(4):e19239. doi: 10.1371/journal.pone.0019239.

5.

Brain regional α-[11C]methyl-L-tryptophan trapping in medication-free patients with obsessive-compulsive disorder.

Berney A, Leyton M, Gravel P, Sibon I, Sookman D, Rosa Neto P, Diksic M, Nakai A, Pinard G, Todorov C, Okazawa H, Blier P, Nordahl TE, Benkelfat C.

Arch Gen Psychiatry. 2011 Jul;68(7):732-41. doi: 10.1001/archgenpsychiatry.2011.16. Epub 2011 Mar 7.

6.

Nutraceuticals in the treatment of obsessive compulsive disorder (OCD): a review of mechanistic and clinical evidence.

Camfield DA, Sarris J, Berk M.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):887-95. doi: 10.1016/j.pnpbp.2011.02.011. Epub 2011 Feb 23. Review.

PMID:
21352883
7.

Serotonin synthesis, release and reuptake in terminals: a mathematical model.

Best J, Nijhout HF, Reed M.

Theor Biol Med Model. 2010 Aug 19;7:34. doi: 10.1186/1742-4682-7-34.

8.

Sleep in obsessive compulsive disorder: polysomnographic studies under baseline conditions and after experimentally induced serotonin deficiency.

Voderholzer U, Riemann D, Huwig-Poppe C, Kuelz AK, Kordon A, Bruestle K, Berger M, Hohagen F.

Eur Arch Psychiatry Clin Neurosci. 2007 Apr;257(3):173-82. Epub 2006 Dec 5.

PMID:
17149537
9.

Role of atypical opiates in OCD. Experimental approach through the study of 5-HT(2A/C) receptor-mediated behavior.

Rojas-Corrales MO, Gibert-Rahola J, Mico JA.

Psychopharmacology (Berl). 2007 Feb;190(2):221-31. Epub 2006 Nov 11.

PMID:
17102981
10.

The current status of association studies in obsessive-compulsive disorder.

Hemmings SM, Stein DJ.

Psychiatr Clin North Am. 2006 Jun;29(2):411-44. Review.

PMID:
16650716
11.

Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in children and adolescents with obsessive-compulsive disorder.

Mössner R, Walitza S, Geller F, Scherag A, Gutknecht L, Jacob C, Bogusch L, Remschmidt H, Simons M, Herpertz-Dahlmann B, Fleischhaker C, Schulz E, Warnke A, Hinney A, Wewetzer C, Lesch KP.

Int J Neuropsychopharmacol. 2006 Aug;9(4):437-42. Epub 2005 Sep 7.

PMID:
16146581
12.

Impact of experimentally induced serotonin deficiency by tryptophan depletion on saliva cortisol concentrations.

Vielhaber K, Riemann D, Feige B, Kuelz A, Kirschbaum C, Voderholzer U.

Pharmacopsychiatry. 2005 Mar;38(2):87-94.

PMID:
15744632
13.

[Hyperactivity and anorexia nervosa: behavioural and biological perspective].

Kohl M, Foulon C, Guelfi JD.

Encephale. 2004 Sep-Oct;30(5):492-9. Review. French.

PMID:
15627053
14.

Hypothalamic digoxin deficiency in obsessive compulsive disorder and la Tourette's syndrome.

Kurup RK, Kurup PA.

Int J Neurosci. 2002 Jul;112(7):797-816.

PMID:
12424821
15.

The effects of tryptophan depletion on mood and psychiatric symptoms.

Van der Does AJ.

J Affect Disord. 2001 May;64(2-3):107-19. Review.

PMID:
11313078
16.

The tryptophan depletion test. Impact on sleep in healthy subjects and patients with obsessive-compulsive disorder.

Huwig-Poppe C, Voderholzer U, Backhaus J, Riemann D, König A, Hohagen F.

Adv Exp Med Biol. 1999;467:35-42.

PMID:
10721036
17.

Mechanisms of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disorders.

Nutt DJ, Forshall S, Bell C, Rich A, Sandford J, Nash J, Argyropoulos S.

Eur Neuropsychopharmacol. 1999 Jul;9 Suppl 3:S81-6. Review.

PMID:
10523062
18.
19.

Role of serotonin in obsessive-compulsive disorder.

Baumgarten HG, Grozdanovic Z.

Br J Psychiatry Suppl. 1998;(35):13-20. Review.

PMID:
9829022
20.
Items per page

Supplemental Content

Loading ...
Write to the Help Desk